SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015173
Filing Date
2021-11-09
Accepted
2021-11-09 08:01:02
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20210930x10q.htm   iXBRL 10-Q 1699086
2 EX-31.1 hrmy-20210930xex31d1.htm EX-31.1 15764
3 EX-31.2 hrmy-20210930xex31d2.htm EX-31.2 16917
4 EX-32.1 hrmy-20210930xex32d1.htm EX-32.1 9705
5 EX-32.2 hrmy-20210930xex32d2.htm EX-32.2 8946
  Complete submission text file 0001558370-21-015173.txt   7264920

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20210930.xsd EX-101.SCH 59109
7 EX-101.CAL hrmy-20210930_cal.xml EX-101.CAL 69597
8 EX-101.DEF hrmy-20210930_def.xml EX-101.DEF 199226
9 EX-101.LAB hrmy-20210930_lab.xml EX-101.LAB 505710
10 EX-101.PRE hrmy-20210930_pre.xml EX-101.PRE 388617
11 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20210930x10q_htm.xml XML 1191222
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 211389956
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences